# OnCo record paper-abou-alfa-phocus-pexa-vec-liver-cancer-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-abou-alfa-phocus-pexa-vec-liver-cancer-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-abou-alfa-phocus-pexa-vec-liver-cancer-2024" ;
  schema:name "PHOCUS: an oncolytic vaccinia virus before sorafenib in liver cancer did worse than sorafenib alone"@en ;
  schema:description "Adding injections of an engineered pox virus before standard liver cancer treatment did not help and the results were worse than the control arm, so the trial was stopped early."@en ;
  schema:url <https://onco.cc/key-papers/paper-abou-alfa-phocus-pexa-vec-liver-cancer-2024/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1159/000533650>, <https://pubmed.ncbi.nlm.nih.gov/38756145/> ;
  schema:sameAs <https://doi.org/10.1159/000533650> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Abou-Alfa GK, Galle PR, Chao Y, et al." ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .